Virtual care for patients with Alzheimer disease and related dementias during the COVID-19 era and beyond

Paula J. Gosse; Charles D. Kassardjian; Mario Masellis; Sara B. Mitchell

doi:10.1503/cmaj.201938

Article Information

vol. 193 no. 11 E371-E377

DOI

https://doi.org/10.1503/cmaj.201938

PubMed

33722828

History

Published online March 15, 2021.

© 2021 Joule Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

Author Information

Paula J. Gosse, BSc,
Charles D. Kassardjian, MD MSc,
Mario Masellis, MD PhD,
Sara B. Mitchell, MD MPH

Faculty of Medicine (Gosse, Kassardjian, Masellis, Mitchell) and Department of Medicine, Division of Neurology ( Kassardjian, Masellis, Mitchell), University of Toronto; Sunnybrook Health Sciences Centre, Department of Medicine, Division of Neurology (Masellis, Mitchell); Department of Medicine, Division of Neurology (Kassardjian), St. Michael’s Hospital; Neurology Quality and Innovation Lab (NQIL) (Kassardjian, Mitchell), University of Toronto; Hurvitz Brain Sciences Research Program (Masellis, Mitchell), Sunnybrook Research Institute; Li Ka Shing Knowledge Institute (Kassardjian), St. Michael’s Hospital, Toronto, Ont.